Literature DB >> 9852923

Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome.

A M Segura1, R E Luna, K Horiba, W G Stetler-Stevenson, H A McAllister, J T Willerson, V J Ferrans.   

Abstract

BACKGROUND: Thoracic aortic aneurysms (TAAs) and valvular insufficiency, the main cardiovascular lesions in Marfan's syndrome, are associated with destruction of connective tissue; however, their pathogenesis remains unclear. METHODS AND
RESULTS: To test the hypothesis that changes in the activity of the matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are responsible for the damage to connective tissue in these lesions, histochemical studies of the immunoreactivity (IR) for MMPs and their tissue TIMPs (MMP-1, MMP-2, MMP-3, MMP-9, TIMP-1, and TIMP-2) were made in TAAs (n = 7) and aortic valves (n = 5) from 7 patients with Marfan's syndrome. All TAAs showed cystic medial necrosis (CMN), with loss of elastic fibers and smooth muscle cells. Extensive areas of myxoid change were found in all aortic valves. Areas of CMN showed no IR for any MMPs or TIMPs. The IR of smooth muscle cells at the borders of areas of CMN was stronger for all MMPs, especially MMP-2 and MMP-9, than in other regions. The surfaces of disrupted elastic fibers showed IR for MMP-2 and MMP-9. Areas of myxoid change showed similar but less pronounced alterations.
CONCLUSIONS: We hypothesize that the defect in fibrillin-1 in Marfan's syndrome leads to (1) formation of elastin that is abnormally aggregated and more easily degraded by MMPs than is normal elastin, (2) upregulation of the synthesis of MMPs, (3) progressive destruction of connective tissue by these enzymes, and (4) development of TAAs and valvular lesions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9852923

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  44 in total

1.  Fibrillin-containing microfibrils are key signal relay stations for cell function.

Authors:  Karina A Zeyer; Dieter P Reinhardt
Journal:  J Cell Commun Signal       Date:  2015-10-08       Impact factor: 5.782

Review 2.  Aortic Involvement in Pediatric Marfan syndrome: A Review.

Authors:  Omonigho Ekhomu; Zahra J Naheed
Journal:  Pediatr Cardiol       Date:  2015-02-11       Impact factor: 1.655

3.  Circulating transforming growth factor-beta in Marfan syndrome.

Authors:  Peter Matt; Florian Schoenhoff; Jennifer Habashi; Tammy Holm; Christel Van Erp; David Loch; Olga D Carlson; Benjamin F Griswold; Qin Fu; Julie De Backer; Bart Loeys; David L Huso; Nazli B McDonnell; Jennifer E Van Eyk; Harry C Dietz
Journal:  Circulation       Date:  2009-07-27       Impact factor: 29.690

4.  Molecular and functional characteristics of heart-valve interstitial cells.

Authors:  Adrian H Chester; Patricia M Taylor
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-08-29       Impact factor: 6.237

Review 5.  Molecular pathogenesis of genetic and sporadic aortic aneurysms and dissections.

Authors:  Ying H Shen; Scott A LeMaire
Journal:  Curr Probl Surg       Date:  2017-02-03       Impact factor: 1.909

6.  Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome.

Authors:  Jorge Oller; Nerea Méndez-Barbero; E Josue Ruiz; Silvia Villahoz; Marjolijn Renard; Lizet I Canelas; Ana M Briones; Rut Alberca; Noelia Lozano-Vidal; María A Hurlé; Dianna Milewicz; Arturo Evangelista; Mercedes Salaices; J Francisco Nistal; Luis Jesús Jiménez-Borreguero; Julie De Backer; Miguel R Campanero; Juan Miguel Redondo
Journal:  Nat Med       Date:  2017-01-09       Impact factor: 53.440

Review 7.  Decellularized matrices for cardiovascular tissue engineering.

Authors:  Francesco Moroni; Teodelinda Mirabella
Journal:  Am J Stem Cells       Date:  2014-03-13

Review 8.  Therapeutics Targeting Drivers of Thoracic Aortic Aneurysms and Acute Aortic Dissections: Insights from Predisposing Genes and Mouse Models.

Authors:  Dianna M Milewicz; Siddharth K Prakash; Francesco Ramirez
Journal:  Annu Rev Med       Date:  2017-01-14       Impact factor: 13.739

9.  Angiotensin II increases matrix metalloproteinase 2 expression in human aortic smooth muscle cells via AT1R and ERK1/2.

Authors:  Chunmao Wang; Xiangyang Qian; Xiaogang Sun; Qian Chang
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-11

10.  AKT2 confers protection against aortic aneurysms and dissections.

Authors:  Ying H Shen; Lin Zhang; Pingping Ren; Mary T Nguyen; Sili Zou; Darrell Wu; Xing Li Wang; Joseph S Coselli; Scott A LeMaire
Journal:  Circ Res       Date:  2012-12-18       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.